Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds
OPreNBiS
1 other identifier
interventional
43
1 country
1
Brief Summary
Study aim : To compare a novel strategy of lesion preparation with noncompliant balloons before implantation of BVS. Hypothesis: Predilatation with non-compliant balloons could facilitate optimal deployment of BVS. By achieving good scaffold apposition a need for post-dilatation could be significantly reduced. This is expected to result in better short- and long-term outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable coronary-artery-disease
Started Mar 2015
Typical duration for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 29, 2018
CompletedFirst Submitted
Initial submission to the registry
April 20, 2018
CompletedFirst Posted
Study publicly available on registry
May 8, 2018
CompletedMay 8, 2018
May 1, 2018
1.8 years
April 20, 2018
May 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Apposition of bioresorbable scaffold immediately after stent implantation following: pre-dilatation with OPN vs. pre-dilatation with standard balloons.
Stent apposition will be assessed based on OCT (optical coherence tomography) visualization.
During the index procedure
Secondary Outcomes (8)
Procedural success defined as successful delivery of the scaffold.
During the index procedure
Need for post-dilatation after initial OCT.
During the index procedure
Scaffold apposition after post-dilatation.
During the index procedure
Periprocedural complications: dissection, slow- or no flow, dissection requiring additional stent implantation.
During the index procedure
Periprocedural myocardial infarction defined as 5x upper reference level elevation of high sensitive Troponin I (in patients with normal pre-procedural Troponin).
During the index procedure
- +3 more secondary outcomes
Study Arms (2)
OPN strategy
EXPERIMENTALThe OPN NC Super High Pressure PTCA Balloon will be used as the study device for lesion preparation for BVS Absorb implantation - OPN strategy of lesion preparation. This balloon has a twin layer balloon construction, which allows a very high pressure resistance of 35 bar. The balloon has a 0.016'' lesion entry profile and is available in sizes between 1.5 and 4.5 mm and lengths of 10, 15 and 20 mm.
standard strategy
ACTIVE COMPARATORPredilatation with standard coronary balloon will be performed for lesion preparation for BVS Absorb implantation - standard strategy of lesion preparation.
Interventions
Predilatation with OPN balloon will be performed as a lesion preparation for BVS Absorb implantation.
Predilatation with standard balloon will be performed as a lesion preparation for BVS Absorb implantation.
Eligibility Criteria
You may qualify if:
- Age \> 18 years.
- Able and willing to give informed consent.
- Willing to comply with specified follow-up evaluations.
- Clinical manifestation of coronary artery disease: stable angina, unstable angina or non-ST-elevation myocardial infarction.
- De novo lesion.
- Angiographic diameter stenosis \> 70 % and/or fractional flow reserve \<0.80.
- Vessel diameter between 2.5 and 4.0 mm.
- One- or two vessel disease (defined as diameter stenosis \> 70 % in vessels with a diameter \> 2.5 mm).
- Up to two lesions in one or two vessels can be treated.
You may not qualify if:
- Patient characteristics
- Pregnant or nursing patient or planned pregnancy in the period up to 1 year following the index procedure.
- Patient with contraindication for 12 months of dual antiplatelet therapy.
- ST-elevation myocardial infarction.
- Any contraindication to the implantation of BVS. Lesion characteristics
- Visible thrombus in coronary angiography
- Chronic total occlusion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KCRIlead
- SIS Medical AGcollaborator
Study Sites (1)
Luzerner Kantonsspital
Lucerne, Switzerland
Related Publications (1)
Cuculi F, Bossard M, Zasada W, Moccetti F, Voskuil M, Wolfrum M, Malinowski KP, Toggweiler S, Kobza R. Performing percutaneous coronary interventions with predilatation using non-compliant balloons at high-pressure versus conventional semi-compliant balloons: insights from two randomised studies using optical coherence tomography. Open Heart. 2020 Jan 23;7(1):e001204. doi: 10.1136/openhrt-2019-001204. eCollection 2020.
PMID: 32076567DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Florim Cuculi, MD, PhD
Luzerner Kantonsspital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
April 20, 2018
First Posted
May 8, 2018
Study Start
March 1, 2015
Primary Completion
December 1, 2016
Study Completion
March 29, 2018
Last Updated
May 8, 2018
Record last verified: 2018-05